Who is sponsoring NCT03159377?

NCT03159377 is sponsored by Sheba Medical Center.

What drugs are being tested in NCT03159377?

Interventions in NCT03159377: Ultra low dose chest CT.

What condition does NCT03159377 study?

NCT03159377 studies Pulmonary Nodule, Multiple.

Is NCT03159377 still recruiting?

NCT03159377 is currently completed. Last updated 15 October 2021.

Last reviewed 2021-10-15 · How we verify

NCT03159377

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ultra-Low Dose CT Denoising for Lung Nodule Detection

Completed Last updated 15 October 2021

What this trial tests

trial testing Ultra low dose chest CT in Pulmonary Nodule, Multiple in 52 participants. Completed in 6 July 2021.

Timeline

4 July 2017

Primary endpoint
31 January 2018

6 July 2021

Quick facts

Lead sponsor	Sheba Medical Center
Status	Completed
Study type	OBSERVATIONAL
Enrollment	52
Start date	4 July 2017
Primary completion	31 January 2018
Estimated completion	6 July 2021
Sites	1 location across Israel

Drugs / interventions tested

Ultra low dose chest CT

Conditions studied

Pulmonary Nodule, Multiple — all drugs for Pulmonary Nodule, Multiple →

Sponsor

Sheba Medical Center

Who can join

Adults 18 to 110, any sex, with Pulmonary Nodule, Multiple. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We will perform an ultra low-dose CT (ULDCT) in addition to a regular chest CT scan for adult patients undergoing a clinically indicated chest CT. Using a recently developed computationally efficient algorithm for the denoising of ULDCT scans after image reconstruction, we will compare the sensitivity, specificity and accuracy of lesion detection with the ULDCT as compared to the regular CT scan.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ultra low dose chest CT

Trials testing the same drug.

NCT03305978 — Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan. · NA · completed

Other Sheba Medical Center trials

Trials by the same sponsor.

NCT07401524 — Carbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum Hemorrhage · Phase 4 · not yet recruiting
NCT07523373 — Facial Nerve Monitoring During Parotid and Facial Surgery Using a Non-Invasive Patch · NA · not yet recruiting
NCT07509229 — 9-cis Beta-Carotene-Rich Extract of Dunaliella Alga in Retinitis Pigmentosa Patients · Phase 1, PHASE2 · not yet recruiting
NCT07405723 — Arm Position and Blood Pressure Measurement Accuracy During Pregnancy · NA · recruiting
NCT07474987 — Portable VR-based Chromatic Pupilloperimeter for Diagnosis and Monitoring of Traumatic Brain Injury · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03159377 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sheba Medical Center
Last refreshed: 15 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03159377.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing